In-Depth Characterization of microRNA Transcriptome in Melanoma

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Kozubek, James ^a,b   Ma, Zhihai ^c   Fleming, Elizabeth ^a   Duggan, Tatiana ^a   Wu, Rong ^a   Shin, Dong Guk ^b   Dadras, Soheil S ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b University of Connecticut   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 203; MICRORNA 204 5P; MICRORNA 211 5P; MICRORNA 23B 3P; MICRORNA 26A 5P; MICRORNA 26B 5P; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASTIC NEVUS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALE; MELANOCYTE; MELANOMA; METASTATIC MELANOMA; NEVUS; NUCLEOTIDE SEQUENCE; PRIMARY TUMOR; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; RNA STRUCTURE; SIGNAL TRANSDUCTION; TUMOR BIOPSY; TUMOR CELL LINE; TUMOR GROWTH; TUMOR INVASION; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOCYTES; MELANOMA; MICRORNAS; MIDDLE AGED; SKIN NEOPLASMS; TRANSCRIPTOME;

EID: 84883420810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072699     Document Type: Article

References (61)

1. Howlader N NA, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. (eds). (2012) SEER Stat Fact Sheets: Skin (excl. Basal and Squamous). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute posted to the SEER web site, 2012 ed. Bethesda, MD: http://seer.cancer.gov/csr/, Accessed May 20, 2013. 1975_2009_pops09/results_single/ sect_01_table.01.pdf.
2. McGinnis KS, Lessin SR, Elder DE, Guerry Dt, Schuchter L, et al. (2002) Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic. Archives of dermatology 138: 617-621.
3. Cerroni L, Barnhill R, Elder D, Gottlieb G, Heenan P, et al. (2010) Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. The American journal of surgical pathology 34: 314-326.
4. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, et al. (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353: 2135-2147.
5. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America 101: 2999-3004.
7. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
8. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.
9. Tagawa H, Seto M, (2005) A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK 19: 2013-2016.
10. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, et al. (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer research 65: 9628-9632.
11. Mueller DW, Rehli M, Bosserhoff AK, (2009) miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 129: 1740-1751.
12. Caramuta S, Egyhazi S, Rodolfo M, Witten D, Hansson J, et al. (2010) MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 130: 2062-2070.
13. Greenberg E, Hershkovitz L, Itzhaki O, Hajdu S, Nemlich Y, et al. (2011) Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs. PLoS One 6: e18936.
14. Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, et al. (2011) microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. The EMBO journal.
15. Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, et al. (2010) Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Molecular cell 40: 841-849.
16. Mazar J, DeYoung K, Khaitan D, Meister E, Almodovar A, et al. (2010) The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One 5: e13779.
17. Chan E, Patel R, Nallur S, Ratner E, Bacchiocchi A, et al. (2011) MicroRNA signatures differentiate melanoma subtypes. Cell Cycle 10.
18. Segura MF, Belitskaya-Levy I, Rose AE, Zakrzewski J, Gaziel A, et al. (2010) Melanoma MicroRNA signature predicts post-recurrence survival. Clinical cancer research: an official journal of the American Association for Cancer Research 16: 1577-1586.
19. Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, et al. (2010) Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer research 70: 4163-4173.
20. Glud M, Rossing M, Hother C, Holst L, Hastrup N, et al. (2010) Downregulation of miR-125b in metastatic cutaneous malignant melanoma. Melanoma research 20: 479-484.
21. Xu Y, Brenn T, Brown ER, Doherty V, Melton DW, (2012) Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. British journal of cancer 106: 553-561.
22. Poliseno L, Haimovic A, Segura MF, Hanniford D, Christos PJ, et al. (2012) Histology-specific microRNA alterations in melanoma. The Journal of investigative dermatology 132: 1860-1868.
23. Griffiths-Jones S, (2006) miRBase: the microRNA sequence database. Methods Mol Biol 342: 129-138.
24. Ma Z, Lui WO, Fire A, Dadras SS, (2009) Profiling and discovery of novel miRNAs from formalin-fixed, paraffin-embedded melanoma and nodal specimens. The Journal of molecular diagnostics: JMD 11: 420-429.
25. Lau NC, Lim LP, Weinstein EG, Bartel DP, (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862.
26. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, et al. (2008) Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome research 18: 610-621.
27. Kuchenbauer F, Morin RD, Argiropoulos B, Petriv OI, Griffith M, et al. (2008) In-depth characterization of the microRNA transcriptome in a leukemia progression model. Genome research 18: 1787-1797.
28. Pacheco I, Buzea C, Tron V, (2011) Towards new therapeutic approaches for malignant melanoma. Expert reviews in molecular medicine 13: e33.
29. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27: 6199-6206.
30. Doeden K, Ma Z, Narasimhan B, Swetter SM, Detmar M, et al. (2009) Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. Journal of cutaneous pathology 36: 772-780.
31. Parameswaran P, Jalili R, Tao L, Shokralla S, Gharizadeh B, et al. (2007) A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing. Nucleic Acids Res 35: e130.
32. Tibshirani R, Hastie T, Narasimhan B, Chu G, (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proceedings of the National Academy of Sciences of the United States of America 99: 6567-6572.
33. Kasprzyk A, Keefe D, Smedley D, London D, Spooner W, et al. (2004) EnsMart: a generic system for fast and flexible access to biological data. Genome research 14: 160-169.
34. Li J, Tibshirani R (2011) Finding consistent patterns: A nonparametric approach for identifying differential expression in RNA-Seq data. Statistical methods in medical research.
35. Ma Z, Swede H, Cassarino D, Fleming E, Fire A, et al. (2011) Up-regulated Dicer expression in patients with cutaneous melanoma. PLoS One 6: e20494.
36. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, et al. (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic acids research 40: W498-504.
37. Friedlander MR, Chen W, Adamidi C, Maaskola J, Einspanier R, et al. (2008) Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol 26: 407-415.
38. Witten D, Tibshirani R, Gu SG, Fire A, Lui WO, (2010) Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC biology 8: 58.
39. Mueller DW, Bosserhoff AK (2010) MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. International journal of cancer Journal international du cancer.
40. Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, et al. (1998) Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 58: 1515-1520.
41. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, et al. (2010) A MicroRNA targeting dicer for metastasis control. Cell 141: 1195-1207.
42. Hanna JA, Hahn L, Agarwal S, Rimm DL (2012) In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA. Laboratory investigation; a journal of technical methods and pathology.
43. Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, et al. (2010) Characterization of the Melanoma miRNAome by Deep Sequencing. PLoS One 5: e9685.
44. Ceol CJ, Houvras Y, Jane-Valbuena J, Bilodeau S, Orlando DA, et al. (2011) The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471: 513-517.
45. Macgregor S, Montgomery GW, Liu JZ, Zhao ZZ, Henders AK, et al. (2011) Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nature genetics 43: 1114-1118.
46. Kelly AD, Hill KE, Correll M, Hu L, Wang YE, et al. (2013) Next-generation sequencing and microarray-based interrogation of microRNAs from formalin-fixed, paraffin-embedded tissue: Preliminary assessment of cross-platform concordance. Genomics 102: 8-14.
47. Meng W, McElroy JP, Volinia S, Palatini J, Warner S, et al. (2013) Comparison of MicroRNA Deep Sequencing of Matched Formalin-Fixed Paraffin-Embedded and Fresh Frozen Cancer Tissues. PLoS One 8: e64393.
48. Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, et al. (2011) miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. The Journal of biological chemistry 286: 16606-16614.
49. Liu S, Tetzlaff MT, Liu A, Liegl-Atzwanger B, Guo J, et al. (2012) Loss of microRNA-205 expression is associated with melanoma progression. Laboratory investigation; a journal of technical methods and pathology 92: 1084-1096.
50. Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, et al. (2010) MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. International journal of cancer Journal international du cancer 126: 2553-2562.
51. Reuland SN, Smith SM, Bemis LT, Goldstein NB, Almeida AR, et al. (2012) MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD). The Journal of investigative dermatology.
52. Noguchi S, Mori T, Otsuka Y, Yamada N, Yasui Y, et al. (2012) Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 in Human Melanoma Cells. The Journal of biological chemistry.
53. Jukic DM, Rao UN, Kelly L, Skaf JS, Drogowski LM, et al. (2010) Microrna profiling analysis of differences between the melanoma of young adults and older adults. Journal of translational medicine 8: 27.
54. Jiang L, Lv X, Li J, Li X, Li W, et al. (2011) The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma. Acta histochemica.
55. Grignol V, Fairchild ET, Zimmerer JM, Lesinski GB, Walker MJ, et al. (2011) miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. British journal of cancer 105: 1023-1029.
56. Hwang SJ, Seol HJ, Park YM, Kim KH, Gorospe M, et al. (2012) MicroRNA-146a suppresses metastatic activity in brain metastasis. Molecules and cells 34: 329-334.
57. Mattia G, Errico MC, Felicetti F, Petrini M, Bottero L, et al. (2011) Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma. Pigment cell & melanoma research 24: 953-965.
58. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, et al. (2008) The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer research 68: 2745-2754.
59. Elson-Schwab I, Lorentzen A, Marshall CJ (2010) MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One 5.
60. Liu S, Tetzlaff MT, Cui R, Xu X, (2012) miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1. The American journal of pathology 181: 1823-1835.
61. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ, (2010) Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. The oncologist 15: 673-682.